Intermittent hypoxia, reoxygenation, and hypercapnia or hypocapnia occur in both adults and children during untreated apnoea and hypopnoea, along with changes in cerebral blood fl ow and sleep fragmentation. These eff ects can result in cognitive defi cits with functional eff ects on work and school effi ciency. The assessment of how obstructive sleep apnoea aff ects cognition depends on the specifi city and sensitivity of the tests, which are rarely developed specifi cally for obstructive sleep apnoea. In this Review, we discuss both the neural adaptive and maladaptive processes in response to hypoxaemia. The net result on cognitive and emotional performance depends on the stage of this dynamic process, eff ects on other body systems, cognitive reserve, and idiosyncratic susceptibility. We also explore the contribution of fragmented sleep, and the disruption of sleep structure, with focus on the eff ect at diff erent times in the development of disease. This Review will address the gap in the underlying pathophysiology of new clinical and translational fi ndings, and argue their contribution to the inherent complexity of the association between obstructive sleep apnoea and the brain.
Introduction
Obstructive sleep apnoea is a highly prevalent, chronic, multisystem disease that remains under recognised in the general population, despite the 20 years that have elapsed since the seminal prevalence report in 1993, 1 and more than 30 years since the acclaimed account of continuous positive airway pressure (CPAP) treatment for the disorder. [1] [2] [3] [4] Epidemiological data suggest the prevalence of obstructive sleep apnoea in the USA has increased by 14-55% since the early 1990s. 5 Similar prevalence has been noted in other countries and specifi c ethnic groups around the world, with clear overall male preponderance until menopause age in women. [6] [7] [8] [9] [10] Obstructive sleep apnoea is usually associated with serious cardiovascular and metabolic comorbidities, with systemic hypertension occurring in up to 50% of patients with obstructive sleep apnoea. 11, 12 Strong associations of obstructive sleep apnoea with old age (used in this Review to refer to patients aged 65 years or over) and obesity, both of which are on the rise, underscore its important public health implications. 11, 13 The syndromic constellation of eff ects of obstructive sleep apnoea on the brain merit particular attention and are the focus of this Review. This disorder is increasingly recognised as a potentially modifi able risk factor for dementia, especially in older adults. [14] [15] [16] A role of obstructive sleep apnoea in seizure aggravation in epilepsy, several neuropsychiatric disorders, and stroke has also been proposed. 2 The progressive changes in sleep quality and structure, along with changes in cerebral blood fl ow, neurovascular and neurotransmitter changes, cellular redox status, and neural regulation in patients with obstructive sleep apnoea could constitute a contributing factor to cognitive decline, which is also seen with healthy ageing but is present to a much greater extent in neurodegenerative diseases. 1, [16] [17] [18] [19] Reduced quality of life, excessive daytime sleepiness, labile interpersonal relationships, increased road traffi c accidents, and decreased work and school effi ciency have all been reported in patients with obstructive sleep apnoea, and these eff ects are not always reversed with treatment. 20 Benefi cial eff ects of treatment on cognitive performance (including vigilance and sleepiness) and neural injury in this disorder (fi gure 1) have been documented in meta-analyses 22, 23 and a meta review. 24 Findings from two studies 25, 26 likewise suggest benefi cial eff ects of CPAP therapy in older people with obstructive sleep apnoea 25 and in those with negligible symptoms. 26 The dearth of fully eff ective treatments for the CNS sequelae of obstructive sleep apnoea is probably a refl ection of poorly understood yet intricate interplay of intermittent hypoxia, reoxygenation, hypercapnia, changes in cerebral blood fl ow, 27 and sleep fragmentation that result from nocturnal episodes of complete or partial pharyngeal obstruction in the disease. 2, 28 We and others have argued that both adaptive and maladaptive processes in response to hypoxaemia occur in the brains of patients with obstructive sleep apnoea. The overall result depends on the stage of this dynamic process, eff ects on other body systems, cognitive reserve, and the idiosyncratic susceptibility of each particular
• Obstructive sleep apnoea is a prevalent, chronic multisystem disease with a high socio-economic burden, which remains under diagnosed in the general population.
• Obstructive sleep apnoea is increasingly recognised as one of the potentially modifi able risk factors for dementia; its multiple eff ects on the central nervous system are acknowledged, although their nature and prognosis are yet to be fully understood.
• Both maladaptive and adaptive pathways are likely initiated in the central nervous system during nocturnal apnoeic and hypopnoeic episodes and ensuing sleep fragmentation, the net result of which will depend on the chronicity of process and idiosyncratic characteristics of each patient.
• In future, multimodal investigative approaches should help elucidate more reliable referencing for the acuity of the pathological process, as well as its reversibility following the treatment.
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patient. 3, 15, 17, [28] [29] [30] [31] [32] This is important since diff erent therapeutic approaches might benefi t diff erent stages and conversely might aggravate damage in some patients. 3, 17, 29 The contribution of frag mented sleep to cognitive and emotional performance of patients with obstructive sleep apnoea has been largely overlooked, 3 and the diversity of studies make it diffi cult to delineate the eff ect of its interplay with continuing neuro infl ammatory processes and ischaemic preconditioning. 
Impaired cognition in patients with sleep apnoea
Over the years, a broad range of psychological problems and neurocognitive impairments have been associated with obstructive sleep apnoea. 24 However, some have argued that detailed analysis of important studies in the specialty supports only a weak association between subjective cognitive complaints in patients with obstructive sleep apnoea and their objective cognitive functioning. 33 This argument has already been used to highlight diff erent results of subjective versus objective complaints in other medical populations such as patients with cancer, and several possible explanations in patients with obstructive sleep apnoea have been suggested. For example, specifi city of tests for cognitive defi cits documented in obstructive sleep apnoea is largely acknowledged as variable. Objective tests for cognition are frequently designed to assess cognitive defi cits in patients with brain injury and as such do not specifi cally assess impairments in obstructive sleep apnoea. 32 Testing provides a snapshot of someone's ability, and it is unlikely that it accurately assesses aspects of cognition in patients with obstructive sleep apnoea that are task dependent or time dependent. In view of the complex neuropathology of obstructive sleep apnoea, a snapshot value of a particular function or ability, as assessed by cognitive tests, might not fully account for its fl uctuation over time and various daytime requirements. Cognitive domains are not unitary con structs, and only the carefully deconstructed analysis of their diff erent subcapacities and their susceptibilities to a range of risks and protective factors specifi c to obstructive sleep apnoea can provide a more realistic assessment of cognitive defi cits. 23 Similarly, several impairments might be secondary to other symptoms of obstructive sleep apnoea, such as sleepiness, or might be a sign of psychological distress. 33, 34 Non-pharmacological and some pharmacological treatments for obstructive sleep apnoea have been shown to improve cognitive outcomes in subpopulations of patients with the disorder. Several meta-analyses 22, 33, 35, 36 suggest that CPAP treatment reduces daytime sleepiness and mood problems, and improves objective cognitive function in patients with obstructive sleep apnoea. Many questions remain unanswered regarding treatment with CPAP, the most pivotal of which are who should receive this treatment, when, and for how long. The full prescriptive protocols, probably in combination with other lifestyle and pharmacological approaches, might only be achieved once the full range of neuropathological changes of obstructive sleep apnoea and its dynamic fi ngerprint (ie, characteristic dynamic changes in multimodal biomarkers) are understood. 3, 28 For example, the benefi cial eff ect of CPAP on symptoms of sleepiness and quality of life in some patients seems to be obtained after only few days of treatment with good adherence, whereas the eff ects of CPAP on other subjective and objective cognitive symptoms are less well defi ned. 37, 38 Two studies 39, 40 report that prolonged treatment might be needed in some patients with severe symptoms. Findings from a study assessing compliance in patients with severe obstructive sleep apnoea showed almost complete recovery of white matter tract integrity with associated substantial improvement in memory, attention, and executive functioning at 2 years of follow-up. 39 Findings of another small pilot study 40 suggested the need for longer treatment with CPAP in elderly patients, and showed that treatment of severe obstructive sleep apnoea in patients with Alzheimer's disease of mild to moderate severity is associated with much slower cognitive decline over 3 years compared with decline in patients not treated with CPAP. 40 Although less striking, evidence from studies of donepezil, physostigmine, and fl uticasone suggests better cognitive Review outcomes in patients with obstructive sleep apnoea treated with these drugs. 41, 42 So far, subjective cognitive complaints have been largely ignored in randomised trials of treatments for obstructive sleep apnoea. In line with the fi ndings discussed in this Review, and because subjective cognitive complaints are known to be linked to quality of life, work productivity, and health-care use in the general population, future studies should take these complaints into account. 33 Some investigators have argued against a reductionist approach to obstructive sleep apnoea-induced brain injury, and point out that emerging research suggests that the association between disease severity and cognitive dysfunction is the product of many susceptibility and protective factors, of which sleep fragmentation, hypoxia, and cognitive reserve are just three aspects. 3, 23, 28 Some other important factors are duration of disease, the role of the blood-brain barrier, hypertension, metabolic dysfunction, systemic infl am mation, cerebral blood fl ow, and genetic susceptibility (eg, apolipoprotein e4 genotype). 23 Most studies in the specialty so far point to substantial defi cits in attention and vigilance, visuospatial and constructional abilities, executive dysfunction, and delayed long-term visual and verbal memory in patients with obstructive sleep apnoea. 24, 43 Several associations have been recognised: the association between worsening general cognitive functioning and severity of hypoxaemia; and the association between dysfunction of attention and vigilance and degree of sleep frag mentation. 24 Consensus is less strong on the eff ects of obstructive sleep apnoea on working memory and short-term memory. 24 Language ability and psychomotor functioning have been largely unaff ected by obstructive sleep apnoea in some studies, 24 whereas others 44 have pointed to psychomotor slowing as the most susceptible cognitive domains, and least responsive to treatment with CPAP. Similar results from several studies 24, 45 have shown impairments in language abilities in patients with severe obstructive sleep apnoea, but have not agreed on whether phonemic or semantic domains are those most aff ected. 45 Neurodevelopmental stages of adolescents and children with obstructive sleep apnoea seem to dictate higher risk for language defi cit. 46 The functional neuroanatomy of obstructive sleep apnoea has been further highlighted in a 3 month study of CPAP treatment, which showed improved cognitive function in several domains that corresponded to an increase in grey matter volume in frontal and hippocampal regions. 47 Similarly, fi ndings from another study showed great improvements in memory, attention, and executive functioning that were associated with the white matter changes after 12 months of treatment with CPAP. 39 Most studies investigating treatments for obstructive sleep apnoea have not accounted for in complete reversal of tissue damage or defi cits in cognition, suggesting that initiation of prolonged treatment might be needed as early as possible in the disease process. [48] [49] [50] Results of studies investigating the cognitive performance and eff ects of treatment in children with obstructive sleep apnoea are similar. 51, 52 In a study of children with sleep disordered breathing, followed up for 4 years, treatment led to improvements in several aspects of neurocognition, collectively classifi ed as performance IQ. 51 Performance IQ represents fl uid intelligence that is indicative of incidental learning and describes one's ability to adapt to new situations. 53 In this study, improve ments were recorded in tasks associated with spatial visualisation, visuo-motor coordination, abstract thought, and nonverbal fl uid reasoning. 51 However, overall improvements in academic ability or behaviour were less clearcut. Worsening of verbal IQ, which, unlike performance IQ, is more likely to be aff ected by formal education and learning experiences, was noted in a treated group. 51 However, a defi nitive explanation for this fi nding was not provided, and no signifi cant association between the reduction in verbal IQ performance and treatment was seen. 51 Conversely, a study in which younger children with sleep disordered breathing were followed up for 12 months of CPAP treatment showed substantial improve ment in academic per formance. 52 The diff erent neurodevelopmental ages of children, and diff erent test variables used, provided a complex clinical dataset from which no defi nite conclusions can be drawn. Never theless, particular patterns and associations seem to be emerging from this and earlier studies, 51, 54 among which the association between performance IQ and slow wave activity (SWA) during non-rapid eye movement (nREM) sleep is perhaps the strongest one. In healthy adults, sleep progresses through nREM stages N1 through N3 followed by a period of REM sleep occurring roughly 60-90 min into the sleep cycle. 55 Cognitive improvements in treated patients with obstructive sleep apnoea might indicate increased stability of brain activity during sleep, allowing for crucial synaptic repair and maintenance to occur, and counteracting toxic eff ects of arousal and hypoxic eff ects of obstructive sleep apnoea. 51, 56 This argument is concordant with fi ndings showing that the neurochemical and gene environments of sleep and sleep activity patterns present crucial periods during which the brain can restore cellular homoeostasis, amplify the signal to noise ratio, and reinforce neuronal circuitry for subsequent cognitive processing demands. 18, 57, 58 Cognitive and emotional sleep Sleep and sleep deprivation alter molecular signalling pathways that regulate synaptic strength, plasticity-related gene expression, and protein translation in a bidirectional manner. 58 Moreover, sleep deprivation can impair neuronal excitability, decrease myelination, and lead to cellular oxidative stress and misfolding of cellular proteins. 58, 59 Findings of an open, cross-sectional, comparative clinical trial 60 suggested associations between oxidative stress markers, sleepiness, and the presence of aff ective symptoms in patients with sleep apnoea.
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Frequent brief awakenings, and ensuing fragmented sleep, have been shown to aff ect cognitive and emotional functioning the next day, in a manner similar to that of total sleep deprivation. 15 Several studies have also attempted to assess whether patients with obstructive sleep apnoea were more susceptible to sleep-loss induced performance defi cits, with special emphasis on driving performance, with varied results. [61] [62] [63] [64] From a practical point of view, it is of major importance to develop reliable and practical bedside tests to help clinicians advise patients on their individual traffi c accident risks. A preliminary study has provided potentially promising data for a specifi c EEG biomarker of neurobehavioural impairment and sleepiness. 62 Preclinical studies suggest that sleep fragmentation independently aff ects brain regions similar to those aff ected by the intermittent hypoxia.
2 Clinical studies of the eff ects of sleep deprivation on cognition in the general population suggest comparable cognitive impairments to those seen in obstructive sleep apnoea. 65 Frequent partial arousals during sleep in patients with this disorder contribute to abnormal sleep architecture and symptoms of excessive daytime somnolence. 2, 28 An independent association between excessive daytime somnolence and cognitive impairment has been seen and several prospective studies have shown that excessive daytime somnolence is associated with an increased risk of cognitive decline and dementia.
14 In a prospective cohort study, 66 lower nocturnal oxygenation and reduction in nREM SWS sleep were associated with the development of microinfarcts and brain atrophy. Conversely, men with longer SWA sleep showed slower cognitive decline than those with shorter SWA sleep. 66 
Cognitive sleep
The eff ect of obstructive sleep apnoea on sleep stages merits particular attention because each of the sleep stages, with its attendant changes in neurophysiology, is associated with facilitation of important functional learning and memory processes. 18 In patients with obstructive sleep apnoea, the proportion of stage N2 nREM sleep has been shown to increase, whereas proportions of stages N1, N3, and REM sleep decrease. 45 Results from experimental studies have shown specifi c impairments of sleep-dependent consolidation for verbal declarative information in patients with obstructive sleep apnoea. 67 Furthermore, several clinical studies suggest disturbed spatiotemporal evolution of sleep spindles in patients with obstructive sleep apnoea during the night. 68, 69 However, the eff ects of sleep fragmentation in patients with obstructive sleep apnoea are not easy to assess, and dynamic analysis of sleep architecture is needed to fully gauge the eff ect on sleep. In one study of mild obstructive sleep apnoea, 70 in which sleep fragmentation was probably not suffi cient to cause relevant decreases in SWS (eg, in N3 nREM) and REM sleep, the exponential decay function of SWA was shown as statistically signifi cantly slower in patients compared with healthy controls. This diff erence was because of the more even distribution of SWA in the patients throughout the night. These results show that mild sleep fragmentation can alter the dynamics of SWA, without substantially decreasing the quantity of SWS and REM sleep, and emphasise the need to perform SWA decay analysis in sleep frag mentation disorders. 70 In the same study, a reduction of spindle activity was seen in N2 and N3 which was not attributed to an increase of SWA. 68, 70 Such a reduction in total spindle density has also been reported in sleep maintenance insomnia, and is probably related to sleep fragmentation. [68] [69] [70] An integrative framework for qualitative reorganisation of memory during sleep has been suggested. The model, proposed by Landmann and colleagues, 71 builds on studies that have shown that sleep helps with the abstraction of rules and the integration of knowledge into existing schemas during nREM SWS. 57, 58, 71 REM sleep, on the other hand, benefi ts creativity that requires the disintegration of existing patterns. 71 Of note, both sleep stages are generally reported as reduced or fragmented in obstructive sleep apnoea, and it is probable that some of the cognitive complaints and memory defi cits described are partly acquired due to this dysregulation. 45, 72 In line with this argument, in one study 73 that investigated neurocognitive defi cits in obstructive sleep apnoea, the number of microarousals during the night was the best predictor of episodic memory defi cit.
Traditionally, obstructive events during nREM sleep have been viewed as associated with greater cognitive defi cits or impaired quality of life, whereas REM sleep events have been shown to be associated with greater sympathetic activity, hypertension, and cardiovascular instability in patients with obstructive sleep apnoea. 74, 75 The role of fragmented REM sleep in spatial navigational memory in patients with obstructive sleep apnoea has been addressed with a physiologically relevant stimulus. 76 During this study, patients spent two diff erent nights in the laboratory, during which they performed timed trials, before and after sleep, on one of two unique 3D spatial mazes. 76 The normal consolidation of sleep was achieved with use of therapeutic CPAP throughout the fi rst night, whereas during the second night, CPAP was only used during the REM sleep stages. Patients showed improve ments in maze performance after a night of normal, uninterrupted sleep, and those improvements were substantially reduced after a night of REM disruption without changes in psychomotor vigilance. Noted cognitive improvements showed statistically signifi cant positive correlation with the mean REM duration across both sleep conditions. 76 In another model, recovery of functionally interconnected networks is proposed to occur during SWA of nREM sleep. 55 This model stresses the importance of the appropriate spatiotemporal revolution of sleep spindles throughout nREM sleep. 55 Sleep spindles are taken to tag those networks that have recovered suffi ciently for their inclusion in the selection process during subsequent sleep. 55 In turn, further excursions into REM sleep then Review allow for safe offl ine reactivation, 55 which checks and deselects fully recovered brain networks from further SWA cycles. Once the required number of SWA cycles is achieved, a presumed transition to wakefulness occurs. 55 Regarding obstructive sleep apnoea-induced cognitive defi cits, it could be argued that this model off ers a robust theoretical framework for the origins of excessive daytime sleepiness and feeling unrefreshed in the morning that is reported by some patients with obstructive sleep apnoea. According to this model, this might be because of the inability to augment nREM SWA and REM sleep during the period of high waking demands. Moreover, in some patients with obstructive sleep apnoea, reduction of REM sleep can lead to dissociation of REM traits to other sleep stages, further aff ecting sleep windows that are crucial for memory formation and consolidation. 18 Findings of several studies have shown that, if high homoeostatic demands are not fully met during sleep, microsleeps can occur in highly active regions of the brain in the subsequent wake period. 55 These microsleeps can lead to concomitant disability in the function associated with that region. 55, 57 To what extent this event takes place in patients with obstructive sleep apnoea, and whether this also contributes to attention and vigilance dysfunction and higher frequency of traffi c accidents noted for this patient group, is not yet fully understood. Previously reported retarded SWA decay throughout the night in patients with even mild obstructive sleep apnoea further supports the notion of non-restorative sleep in obstructive sleep apnoea. 70 The degree of atrophy in the medial prefrontal cortex, an area that is associated with the generation of slow waves and one that is thought to be independently aff ected by obstructive sleep apnoea (fi gure 1), predicts the extent of impaired SWA in elderly people, and results in impaired overnight episodic hippocampal memory consolidation (fi gure 2A). 19, 58 Clinical improve ment of SWA in older adults has been proposed to represent a novel treatment for mitigating cognitive decline in later life. 19 Older adults, who express fewer prefrontal fast sleep spindles than younger adults, have shown a proportional impairment in hippocampal functioning during the subsequent wake periods, and a subsequent defi cit in the ability to form new episodic memories. 78 Fast sleep spindles represent part of a coordinated nREM sleep-dependent memory Atrophy can mediate the degree of SWA disruption, whereas SWA in turn can mediate the degree of impaired memory retention. 19 SWA activity disruption probably also leads to circumscribed cortical regions of increased cellular stress. 59 (B) Emotional sleep: conceptual schematics of "the sleep to forget and sleep to remember" 77 model are shown. 77 Over one or several nights and many repetitions of this REMS mechanism, sleep transforms an emotional memory into a memory of an emotional event that is no longer emotional. SWA=slow wave activity. REMS=rapid eye movement sleep. Reproduced with permission and adapted from Mander and colleagues, 19 Picchioni and colleagues, 59 and Goldstein and colleagues.
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Review mechanism, and hippocampal sharp-wave ripples are thought to provide feedback excitation, which initiates neuroplasticity in spindle-activated cortical neurons. 58 Relative to slow sleep spindles, fast sleep spindle events are associated with greater hippocampal activation and greater hippocampal-cortical functional connectivity. 15, 78 In a study of spindle frequency changes in obstructive sleep apnoea, patients with obstructive sleep apnoea persisted in displaying a great proportion of slow spindles in frontal, central, and parietal regions during the night, unlike healthy controls, sugges0ting that deregulated spindle formation might be another factor contributing to cognitive complaints in patients with obstructive sleep apnoea. 68 In another study, the sleep architecture of patients with mild obstructive sleep apnoea showed a high degree of sleep fragmentation resulting in a diff erent time course of SWA and a decreased sleep spindle index when compared with controls. 70 Taken together, these studies further highlight the possible role for obstructive sleep apnoea brain injury in the initiation or acceleration of cognitive decline (fi gure 2A) in older adults, although the exact pathophysiology of this association remains elusive.
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Emotional sleep
The fi ndings of studies that build on long-standing clinical fi ndings of co-occurring mood and sleep disorders support a bidirectional association between sleep and the function of brain circuitry associated with emotions. 77 Various mental health issues, such as aff ective disorders, emotional instability, and depression, are highly prevalent in individuals with obstructive sleep apnoea, with some studies reporting that up to 63% of individuals are aff ected despite substantial heterogeneity and high risk of bias. [80] [81] [82] [83] Evidence from various studies is suggestive of a role for REM sleep in selective emotional memory processing and sleep-dependent emotional memory depotentiation (fi gure 2B). 77 Moreover, REM sleep is suggested to play a part in recalibrating the sensitivity and specifi city of the brain's response to positive and negative emotional events. 77 This eff ect probably occurs at least partly as a result of modulation of noradrenergic brain stem activity and the responsive profi les of the amygdala and medial prefrontal cortex, two regions crucial for detecting emotional salience. 77 Of all psychiatric disorders, the evidence for increased prevalence of obstructive sleep apnoea is particularly strong for major depressive disorder and post-traumatic stress disorder, 82, 84 which are both independently associated with REM sleep disturbance. Even though the causal association between these aff ective disorders and obstructive sleep apnoea is unclear and is probably multifactorial, the potential sleep mechanics underlying their interaction is worthy of further consideration.
Post-traumatic stress disorder is independently associated with decreases in the total time spent in REM sleep, with marked fragmentation of REM sleep suggestive of arousal-related awakenings from REM sleep linked to adrenergic surges. 77 CPAP adherence, and therefore eff ectiveness, has been shown to be reduced in veterans with post-traumatic stress disorder and comorbid obstructive sleep apnoea. 82 Based on our knowledge of sleep defi cits induced by obstructive sleep apnoea, it can be argued that in patients with posttraumatic stress disorder and comorbid obstructive sleep apnoea, the additive eff ect of sleep disturbance can further impair the quantity and quality of REM sleep. Sleep disturbance probably aff ects the noradrenergic housekeeping function of REM sleep, since it has been shown that REM sleep reduces, and probably restores, concentrations of noradrenaline to baseline, allowing for optimum wakeful functioning. 77 More specifi cally, several studies suggest that quiescence of activity in the locus coeruleus (a brain stem structure and a source of noradrenergic input) throughout REM sleep restores the appropriate next-day tonic-phasic response specifi city (ie, appropriate adrenergic response to resting state and stimulus) within the emotional salience network (eg, locus coeruleus, amygdala, and medial prefrontal cortex). 77 Obstructive sleep apnoea induced REM fragmentation could further aggravate the hyperadrenergic state of some patients with post-traumatic stress disorder, and lead to decreased connectivity between the prefrontal cortex and amygdala, and exaggerated amygdala reactivity. 77 The functional outcome might be an aggravated disease course and worse prognosis. 77 In a prospective study, higher nocturnal oxygenation during REM sleep was associated with less gliosis and neuronal loss in the locus coeruleus. 66 Major depression, on the other hand, is associated with exaggerated REM sleep qualities and reduced monoamine activity. 77 The fi ndings of several studies suggest a relationship between depression and obstructive sleep apnoea. 79 In some patients with obstructive sleep apnoea, fragmented REM sleep can precipitate a vicious cycle of impaired regulation and rebound REM augmentation. Along with concomitant changes in neurotransmitter systems caused by hypoxaemia, this cycle might lead to further reduction in monoamine activity, increased negative rumination, and ensuing depression in genetically predisposed individuals. Through its eff ects on REM sleep, comorbid obstructive sleep apnoea might also lead to dysfunctional memory trace consolidation and depotentiation of emotional memory from previous aff ective experiences. 77 This might result in a condition of chronic anxiety within autobiographical memory networks (fi gure 2B). 77 In a meta-analysis of randomised trials of treatment of obstructive sleep apnoea, a substantial improvement in depressive symptoms was reported. 81 Even though all theoretical constructs of a bidirectional association between sleep in obstructive sleep apnoea and psychiatric disorders discussed in this Review are indirectly supported by animal and neuroimaging Review studies of sleep, 77 their true mechanisms are probably more complex.
Intermittent hypoxia, neuroinfl ammation, and ischaemic conditioning
The cognitive and emotional eff ects of obstructive sleep apnoea are equally attributable to oxidative and neuroinfl ammatory eff ects on the emotional salience network. 3, 28, 79 In obstructive sleep apnoea, repetitive occlusions of the upper airway lead to intermittent hypoxia and recurrent hypoxaemia, typically characterised by short cycles of hypoxia and reoxygenation. 29 However, the patterns vary greatly between patients and, depending on the idiosyncratic characteristics of each individual, the end results might be either adaptive or maladaptive. 29 The outcome will also depend on the dynamic interplay between the specifi c type, amount, duration, and frequency of reactive oxygen and nitrogen species produced, the intracellular localisation, and the microenvironmental antioxidant activity. 17 Additional interplay depends on factors such as genetic makeup, nutrition, and other lifestyle-related variables, all of which aff ect the redox status. 17, 29 Various studies suggest that the severity of hypoxia, its duration, and cycle frequency, are fun damental determinants of outcomes (fi gure 3A). 85 For example, short, mild, and lower cycle frequency is generally acknowledged to generate benefi cial and adaptive responses in the brain, such as ischaemic preconditioning. 29 Conversely, chronic, moderate to severe, and high frequency intermittent hypoxia can induce maladaptive disruption of homoeostatic mecha nisms, leading to dysfunction and sterile neuro infl ammation (ie, infl ammation not caused by the infective agent). 17, 29 Ischaemic preconditioning represents a generalised adaptation to ischaemia by various cells. 30, 86 In obstructive sleep apnoea, induction of ischaemic preconditioning is thought to be caused by the activation of several gene programmes, including hypoxia inducible factor-1, vascular endothelial growth factor, erythropoietin, atrial natriuretic peptide, and brain-derived neurotrophic factor. 87, 88 Various end mechanisms and pathways play a part, including those of long-term facilitation of phrenic motor output, chemorefl ex activation, vascular remodelling, neo-angiogenesis, productive autophagy, reactive gliosis, various synaptic changes, and modulation of adult hippocampal neurogenesis (fi gure 4).
17,94-98 CPAP treatment of obstructive sleep apnoea partly reverses the damage in hippocampal regions, and ameliorates some of the associated cognitive defi cits, possibly by modulating adult neurogenesis. 47 In a neuroimaging study, coexistence of hypotrophic and hypertrophic changes in the brains of patients with obstructive sleep apnoea was taken to show the evolving nature of obstructive sleep apnoea-associated brain injury. 31 Persisting maladaptive neuroinfl ammatory processes are proposed to exist alongside adaptive mechanisms of increased brain plasticity and ischaemic pre con ditioning. 31, 86, 89, 99, 100 In a study that compared the cognitive performance of patients with high and low levels of hypoxaemia, an unexpected benefi t of higher hypoxaemia on memory was shown in a carefully matched clinical cohort, after controlling for demographic factors and other aspects of obstructive sleep apnoea severity. 101 Another powerful central neuroprotective adaptive mechanism for ischaemic events has been shown following the activation of the intrinsic neurons of the cerebellar fastigial nucleus. 102 Neurostimulation of these nuclei seems to provide protective reduced excitability of cortical neurons during subsequent ischaemic episodes, and leads to reduced immunoreactivity of cerebral microvessels. 3 The compensatory entraining of the cerebellum by hypertrophic hippocampi has been proposed to occur in some young patients with mild obstructive sleep apnoea. 31 Although there are no direct monosynaptic anatomical connections between hippocampi and cerebellum, their connectivity is thought to be important for the control of movement under states of heightened emotion and novel conditions, and for associative learning. 3 Failed adaptation of cerebellar networks in response to injury led to cognitive defi cits and hyperactivity, distractibility, ruminative behaviours, dysphoria, and depression in some patients. Review studies also suggest that, under specifi c conditions, intermittent hypoxia can increase immune defences without exacerbating infl ammation. 17, 29 In animals, shortlasting hypoxic exposures mimicking obstructive sleep apnoea have been associated with recruitment of bonemarrow derived pluripotent stem cells, which showed upregulation of stem cell diff erentiation pathways, particularly involving central nervous system development and angiogenesis. 29 Maladaptive eff ects of intermittent hypoxia include neuroinfl ammation, and although the exact neuro cellular sources for associated processes are still incompletely defi ned, activation of astroglia is probably important. 17, 32 Oligodendrocytes, the myelin-producing cells of the CNS, are selectively sensitive to hypoxia and sleep fragmentation. 104, 105 Subsequent loss of chemical buff ering functions can ultimately contribute to pathological processes, such as increased glial pro liferation and microglial activation (fi gure 3B). 32 Astroglial and microglial cells have crucial roles in regu lation of regional blood fl ow and infl ammatory pro cesses in the brain, and are essential in the coordination of bio energetics through lactate transport. 32 Under normal conditions, microglia in the healthy CNS have a surveillance phenotype that synthesises and releases neuroprotective growth and trophic factors. 32 However, severe and protracted hypoxia can activate microglia toward a toxic, pro-infl ammatory phenotype that triggers pathology, including hippocampal apoptosis, impaired synaptic plasticity, and cognitive impairment. 32 Neuro infl ammation has been shown to independently raise the brain's sensitivity to stress, resulting in stress-related neuropsychiatric disorders, such as anxiety or depression. 106 Dynamic changes in transcription of infl ammatory genes have been shown after exposure to intermittent hypoxia, with expression of most infl ammatory markers increasing over time. 32 Increased concentrations of prostaglandin E2 in neural tissue have been noted in hippocampal and cortical regions accompanied by lipid peroxidation of polyunsaturated fatty acids. 32 Increased carbonylation and nitrosylation-induced oxidative injury have been shown to emerge in susceptible brain regions and promote increased excessive daytime somnolence. 17, 32 Toll-like receptor 4 (TLR4) expression and activity is increased on monocytes of patients with obstructive sleep apnoea, 107 and ligands for TLR4 are increased in the serum of children with obstructive sleep apnoea. 107 The microglia of the cortex and brainstem show TLR4 expression after chronic intermittent hypoxia, which is postulated to have a region specifi c and diff erential (adaptive or maladaptive) role. 107 This fi nding is of particular interest since TLR4 has also been strongly implicated in several infl ammatory and neurodegenerative disorders, including vascular dementia and Alzheimer's disease. 107 In cognitively healthy adults, intermittent hypoxia has been associated with increases in phosphorylated and total tau and amyloid β 1-42 concentrations in cerebral spinal fl uid.
14 Cerebral amyloidogenesis and tau phosphorylation, key com ponents of Alzheimer's pathology, along with neuronal degeneration and axonal dysfunction, have been shown in cortex and brainstems of animals exposed to intermittent hypoxia. 15 These fi ndings support a role for neuroinfl ammatory processes in cognitive and emotional defi cits of patients with obstructive sleep apnoea. They further suggest a close association between hypoxaemia induced maladaptive processes and dementia (fi gure 3C). is the archetypical rhythmic activity in the hippocampus (structure shown here in rainbow colours), which runs from the dentate gyrus, to CA3/CA1 of the hippocampus, and fi nally to the entorhinal cortex. 89 Hippocampal θ is thought to modulate the functional properties of the cerebellum and to govern hippocampal neurogenesis. 89 A decrease in θ band occurs after apnoea and hypopnoea events in some patients with sleep apnoea. 90 CPAP normalises these EEG changes. 91 Hypofunctioning fornix (signifi ed here by red dotted line) likely alters neurogenesis in the dentate gyrus and possibly contributes to mild cognitive decline in obstructive sleep apnoea. 92, 93 CPAP= continuous positive airway pressure. EEG=electroencephalography. Reproduced with permission from Rosenzweig and colleagues.
Conclusions and future directions
Disruption of sleep physiology by obstructive sleep apnoea is an underappreciated factor, which, together with hypoxaemia and other already recognised factors, might further aggravate age-related memory defi cits. 15, 16, 19, 78 Clinically, this dynamic interplay also under scores many subjective and objective cognitive and emotional complaints in some patients. 77, 79 An understanding of the proportional eff ect of these factors is a major challenge because they occur simultaneously, probably target similar neurocircuitry, and probably share the same end-stage adaptive and maladaptive cellular mechanisms. 2, 3 Per sistent defi cits, even after long-term treat ment with CPAP in some patients, suggest that early detection of the CNS sequelae in obstructive sleep apnoea is essential so that appropriate treatment is given before irreversible atrophic and metabolic changes occur. However, the timing and the duration of treatment, and optimum treat ment population, are still unclear and should be addressed in future prospective randomised control studies.
Studies discussed in this Review strongly suggest that tapping into the therapeutic potential of ischaemic preconditioning, while working on ameliorating the acute and chronic eff ects of neuroinfl ammation, could off er legitimate new therapeutic targets in obstructive sleep apnoea. 14, 15, 17, 29, 32 Although in their infancy, studies of clinical approaches that target the sleep disturbance arm of this intricate equation advocate substantial potential future treatment interventions. 14, 16, 78 In conclusion, fi ndings raise valid questions about the mechanics of associations between obstructive sleep apnoea, various cognitive and emotional defi cits, and dementia, and further highlight the public-health importance of detecting and targeting those at highest risk for cognitive decline.
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